NCT00006361
- Conditions
- Carcinoma, Carcinoma of Unknown Primary, Carcinoma, Squamous Cell, +23 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Clinical trial condition
Nasopharyngeal Neoplasms
Explore clinical trials studying Nasopharyngeal Neoplasms. Study availability and eligibility vary by location and protocol.
146 public trials
28 recruiting studies
Nasopharyngeal Neoplasms trial results
Completed
Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
NCT00436800
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +7 more
- Locations
-
- Sanofi-Aventis Administrative Office Hong Kong
NCT00078494
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +7 more
- Locations
-
- National Institutes of Health Clinical Center (CC) Bethesda, Maryland, United States
Active, Not Recruiting
Oral Mucositis Management in Patients Receiving Radiation for Head and Neck Cancer: An Evaluation of a Barrier Based Treatment
NCT07697287
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +20 more
- Locations
-
- Juravinski Cancer Centre Hamilton, Ontario, Canada
NCT04925544
- Conditions
- Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
- Locations
-
- Stanford University Stanford, California, United States
Active, Not Recruiting
Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients
NCT02253238
- Conditions
- Dehydration, Head and Neck Cancer, Head and Neck Neoplasms, +20 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
NCT03074513
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Adenoma, +63 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer
NCT05261750
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Cancer, Nasopharyngeal Diseases, +8 more
- Locations
-
- PT Prodia StemCell Indonesia Jakarta, Indonesia
Active, Not Recruiting
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
NCT05239143
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Cancer, +66 more
- Locations
-
- University of California, Irvine Medical Center Irvine, California, United States
- Cedars Sinai Medical Center Los Angeles, California, United States
- University of California, San Diego San Diego, California, United States
- University of California, San Francisco San Francisco, California, United States
Active, Not Recruiting
Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT05807880
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +7 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China